- $42.41m
- $42.17m
- 12
- 38
- 27
- 15
Annual balance sheet for IR-MED, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.235 | 1.87 | 2.81 | 3 | 0.767 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.013 | 0.218 | 0.067 | 0.055 | 0.051 |
Prepaid Expenses | |||||
Total Current Assets | 0.248 | 2.08 | 2.88 | 3.06 | 0.848 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.007 | 0.006 | 0.031 | 0.226 | 0.14 |
Other Long Term Assets | |||||
Total Assets | 0.255 | 2.09 | 2.94 | 3.29 | 0.999 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.189 | 0.523 | 0.395 | 0.662 | 0.473 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.336 | 0.689 | 0.572 | 0.702 | 0.634 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.081 | 1.4 | 2.37 | 2.59 | 0.365 |
Total Liabilities & Shareholders' Equity | 0.255 | 2.09 | 2.94 | 3.29 | 0.999 |
Total Common Shares Outstanding |